Antibiotic Use Among Infants Admitted to Neonatal Intensive Care Units

Dustin D Flannery; Alvaro Zevallos Barboza; Sagori Mukhopadhyay; Kelly C Wade; Jeffrey S Gerber; Di Shu; Karen M Puopolo

doi:10.1001/jamapediatrics.2023.3664

Antibiotic Use Among Infants Admitted to Neonatal Intensive Care Units

JAMA Pediatr. 2023 Dec 1;177(12):1354-1356. doi: 10.1001/jamapediatrics.2023.3664.

Authors

Dustin D Flannery¹, Alvaro Zevallos Barboza¹, Sagori Mukhopadhyay¹, Kelly C Wade¹, Jeffrey S Gerber², Di Shu³, Karen M Puopolo¹

Affiliations

¹ Division of Neonatology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
² Division of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
³ Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia.

PMID: 37812442
PMCID: PMC10562984 (available on 2024-10-09)
DOI: 10.1001/jamapediatrics.2023.3664

No abstract available

Plain language summary

This cross-sectional study examines antibiotic exposure, days of therapy, types of antibiotics, and changes in use patterns among newborns in neonatal intensive care units (NICUs) across the US from 2009 to 2021.

Publication types

Research Support, U.S. Gov't, P.H.S.

MeSH terms

Anti-Bacterial Agents* / therapeutic use
Hospitalization
Humans
Infant
Infant, Newborn
Intensive Care Units, Neonatal*
Risk Factors

Substances

Anti-Bacterial Agents

Grants and funding

K08 HS027468/HS/AHRQ HHS/United States